dendreon, page-31

====Dendreon: Targeting Cancer, Transforming Lives
--Summary of Phase 3 IMPACT Trial Results Presented at AUA Meeting, Webcast Conference Call,
--April 28, 2009

http://files.shareholder.com/downloads/DNDN/617742340x0x290327/0d56dd47-8426-46dd-ab31-705983b009ca/DNDN_42809_IMPACT_Webcast_Slides_FINAL.pdf

===Conclusions of IMPACT Study===
1. First active immunotherapy to demonstrate improvement in
overall survival for advanced prostate cancer
2. Highly favorable benefit to risk profile
3. Short duration of therapy
4. Potential to create new treatment paradigm in oncology
5. Validates potential to apply platform across different cancers

===Dendreon has the potential to fundamentally change the way cancer is treated===

Wli: yes, it opens a door to prime our immune system to identify the cancer cells, attack the cancer cells, kill the cancer cells, and get the dead cancer cells out of the body.

The fundamental breakthrough to show the ideas work in mass production. That is fabulous even it would have to fight to go through the tough FDA regulation. If it could get approval, it would get the monopoly status. It is true to PRR too.

DNDN and PRR go!